{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:02:49Z","timestamp":1749268969093,"version":"3.41.0"},"reference-count":21,"publisher":"Gobierno de Navarra","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An Sist Sanit Navar"],"published-print":{"date-parts":[[2019,12,5]]},"DOI":"10.23938\/assn.0720","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T12:28:21Z","timestamp":1576844901000},"page":"345-349","source":"Crossref","is-referenced-by-count":3,"title":["Secondary glomerulonephritis in neurofibromatosis type 1. Two case reports"],"prefix":"10.23938","volume":"42","member":"10024","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. JETT K, FRIEDMAN JM. Clinical and genetic aspects of Neurofibromatosis. Genet Med 2010; 12: 1-11. https:\/\/doi.org\/10.1097\/GIM.0b013e3181bf15e3","DOI":"10.1097\/GIM.0b013e3181bf15e3"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. UEDA K, AWAZU M, KONISHI Y. Persistent hypertension despite successful dilation of a stenotic renal artery in a boy with neurofibromatosis type 1. Am J Med Genet A 2013; 161A: 1154-1157. https:\/\/doi.org\/10.1002\/ajmg.a.35829","DOI":"10.1002\/ajmg.a.35829"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. DUAN L, FENG K, TONG A. Renal artery stenosis due to neurofibromatosis type 1: case report and literature review. Eur J Med Res 2014; 19: 1. https:\/\/doi.org\/10.1186\/2047-783X-19-17.","DOI":"10.1186\/2047-783X-19-17"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. FRANZ DN, WEISS BD. Molecular therapies for tuberous sclerosis and neurofibromatosis. Curr Neurol Neurosci Rep 2012; 12: 294-301. https:\/\/doi.org\/10.1007\/s11910-012-0269-4","DOI":"10.1007\/s11910-012-0269-4"},{"key":"ref4","unstructured":"5. SHIBATA T, KUDOH K, ISHII T. A case of membranous nephropathy associated with von Recklinghausen's disease. Kidney Dial 1990; 29: 145-148."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. DE CARIDI G, MASSARA M, SPINELLI F. Uncommon case of symptomatic left renal vein compression caused by neurofibroma. Asian Cardiovasc Thorac Ann 2016; 24: 492. https:\/\/doi.org\/10.1177\/0218492315573675","DOI":"10.1177\/0218492315573675"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. GUI X, ZHENG Y. Renal artery aneurysm at the hilum secondary to neurofibromatosis type I. Eur J Vasc Endovasc Surg 2015; 49: 464. https:\/\/doi.org\/10.1016\/j.ejvs.2015.01.022","DOI":"10.1016\/j.ejvs.2015.01.022"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. GERSCH, M. S, TALOR, Z. Focal segmental glomerular sclerosis in a patient with neurofibromatosis type I. Am J Kidney Dis 2006; 47: 17-19. https:\/\/doi.org\/10.1053\/j.ajkd.2005.09.017","DOI":"10.1053\/j.ajkd.2005.09.017"},{"key":"ref8","unstructured":"9. TOTH T, TRINN C, SIMON L, NAGY J. A case of membranous glomerulonephritis associated with Recklinghausen's neurofibromatosis. Clin Nephrol 1996; 4: 271-272 ."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. KOKUBO T, HIKI Y, HORII A, KOBAYASHI Y. RECKLINGHAUSEN'S neurofibromatosis associated with membranous nephropathy. Nephron 1993; 6: 486. https:\/\/doi.org\/10.1159\/000187543","DOI":"10.1159\/000187543"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. TANIGUCHI Y, YORIOKA N, KANBE M, OKUSHIN S, ODA H, NISHIDA Y et al. Parent and child cases of IgA nephropathy associated with von Recklinghausen's disease. Nephron 1997; 75: 113-114. https:\/\/doi.org\/10.1159\/000189515","DOI":"10.1159\/000189515"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. HYUN JI, MIN JW, LEE HM. Minimal changes nephrotic syndrome showing complete remission after resection of a neurofibroma in a type I neurofibromatosis patient. Korean J Intern Med 2017; 32: 186-189. https:\/\/doi.org\/10.3904\/kjim.2015.016","DOI":"10.3904\/kjim.2015.016"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal Change Disease","volume":"12","author":"VIVARELLI","year":"2017","unstructured":"13. VIVARELLI M, MASELLA L, RUGGIERO B. Minimal Change Disease. Clin J Am Soc Nephrol 2017; 12: 332-345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/ndt\/gfg1060","article-title":"Secondary minimal changes disease","volume":"18","author":"GLASSOCK","year":"2003","unstructured":"14. GLASSOCK RJ. Secondary minimal changes disease. Nephrol Dial Transplant 2003; 18: 52-58.","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. DOGAN A. Classification of amyloidosis by mass spectometry-based proteomics. En: Amyloid and related disorders. Surgical Pathology and clinical correlations. Pickens MM , Dogan A; Herrera GA. Cham: Humana Press, 2012: 261-272. https:\/\/doi.org\/10.1007\/978-1-60761-389-3_21","DOI":"10.1007\/978-1-60761-389-3_21"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. HSUEH YP, ROBERTS AM, VOLTA M. Bipartite Interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans. J Neurosci 2001; 21: 3764-3770. https:\/\/doi.org\/10.1523\/jneurosci.21-11-03764.2001","DOI":"10.1523\/JNEUROSCI.21-11-03764.2001"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. DE SCHEPPER S, BOUCNEAU J, WESTBROEK W, MOMMAAS M, ONDERWATER J, MESSIAEN L et al. Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes. J Invest Dermatol 2006; 126: 653-659. https:\/\/doi.org\/10.1038\/sj.jid.5700087","DOI":"10.1038\/sj.jid.5700087"},{"key":"ref17","unstructured":"18. ABRAMOWICZ A, GOS M. Neurofibromin in neurofibromatosis type 1- mutations in NF1 genes as a cause of disease. Dev Period Med 2014; 18: 297-306."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. AFSHINNIA F, VEGA-WARNER V, KILLEN P. Focal segmental glomerulosclerosis in association with neurofibromatosis type 1: a case report and proposed molecular pathways. Clin Kidney J 6, 2013: 208-210. https:\/\/doi.org\/10.1093\/ckj\/sft010","DOI":"10.1093\/ckj\/sft010"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. GODEL M, HARTLEBEN B, HERBACH N, LIU S, ZSCHIEDRICH S, LU S et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 2011; 121: 2197-2209. https:\/\/doi.org\/10.1172\/jci44774","DOI":"10.1172\/JCI44774"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. ITO N. mTOR activation triggers the unfolded protein response in pododyctes and leads to nephrotic syndrome. Lab Invest 2011; 91: 1584-1595. https:\/\/doi.org\/10.1038\/labinvest.2011.135","DOI":"10.1038\/labinvest.2011.135"}],"container-title":["Anales del Sistema Sanitario de Navarra"],"original-title":[],"link":[{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/70903\/47194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T08:19:12Z","timestamp":1749197952000},"score":1,"resource":{"primary":{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/70903\/47194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,12]]}},"URL":"https:\/\/doi.org\/10.23938\/assn.0720","relation":{},"ISSN":["1137-6627"],"issn-type":[{"type":"print","value":"1137-6627"}],"subject":[],"published":{"date-parts":[[2019,12,5]]}}}